Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316649861> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4316649861 abstract "1’-acetoxychavicol acetate (ACA)-loaded nanostructured lipid carriers (NLCs) were formulated for prostate cancer therapy and to determine the optimal therapeutic dose, we developed a rapid, specific, and accurate reversed-phase high-performance liquid chromatography (RP-HPLC) method to quantify the ACA content in NLCs. The method was validated according to International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. Chromatographic separation of ACA from the lipid components was performed with an Agilent 1220 Infinity LC system and ultraviolet detector using an Agilent Poroshell C18 column (4.6 x 250.0 mm). The mobile phase consisted of acetonitrile and water (80:20 [v/v]) with a flow rate of 0.8 mL/min in isocratic mode. Linearity of the standard curve was assessed at an ACA concentration range of 5-200 µg/mL, and a 1/x weighted linear regression was adopted for the calibration curve. The calculated limits of detection and quantification were 0.59 µg/mL and 1.79 µg/mL, respectively. The mean percent recovery of ACA was 100.02% (relative SD, 2%), and the coefficients of variation for intraday and interday assays were within the values required by the ICH. We also demonstrated robustness of the method by altering the mobile phase ratio and flow rate. Furthermore, we proved specificity of the method for ACA by comparing chromatograms of the blank NLC and ACA-NLC. Hence, we effectively used this validated method to determine the drug-loading capacity and entrapment efficiency of the NLCs." @default.
- W4316649861 created "2023-01-17" @default.
- W4316649861 creator A5002913240 @default.
- W4316649861 creator A5011853721 @default.
- W4316649861 creator A5017800148 @default.
- W4316649861 date "2022-01-01" @default.
- W4316649861 modified "2023-10-14" @default.
- W4316649861 title "Development and validation of a reversed-phase HPLC method for quantification of 1’-acetoxychavicol acetate content in a nanostructured lipid carrier formulation" @default.
- W4316649861 cites W1734250133 @default.
- W4316649861 cites W1950865243 @default.
- W4316649861 cites W1964366044 @default.
- W4316649861 cites W1968977462 @default.
- W4316649861 cites W1976169140 @default.
- W4316649861 cites W1990158411 @default.
- W4316649861 cites W2070068066 @default.
- W4316649861 cites W2086508409 @default.
- W4316649861 cites W2090757343 @default.
- W4316649861 cites W2091029411 @default.
- W4316649861 cites W2117150213 @default.
- W4316649861 cites W2134275210 @default.
- W4316649861 cites W2140820328 @default.
- W4316649861 cites W2141162588 @default.
- W4316649861 cites W2144320609 @default.
- W4316649861 cites W2151285320 @default.
- W4316649861 cites W2163419135 @default.
- W4316649861 cites W2163560321 @default.
- W4316649861 cites W2163625007 @default.
- W4316649861 cites W2611315450 @default.
- W4316649861 cites W2611397066 @default.
- W4316649861 cites W2615995139 @default.
- W4316649861 cites W2687967611 @default.
- W4316649861 cites W2915428184 @default.
- W4316649861 cites W787538427 @default.
- W4316649861 doi "https://doi.org/10.1590/s2175-97902022e20627" @default.
- W4316649861 hasPublicationYear "2022" @default.
- W4316649861 type Work @default.
- W4316649861 citedByCount "0" @default.
- W4316649861 crossrefType "journal-article" @default.
- W4316649861 hasAuthorship W4316649861A5002913240 @default.
- W4316649861 hasAuthorship W4316649861A5011853721 @default.
- W4316649861 hasAuthorship W4316649861A5017800148 @default.
- W4316649861 hasBestOaLocation W43166498611 @default.
- W4316649861 hasConcept C113196181 @default.
- W4316649861 hasConcept C119128265 @default.
- W4316649861 hasConcept C121332964 @default.
- W4316649861 hasConcept C172120300 @default.
- W4316649861 hasConcept C179998833 @default.
- W4316649861 hasConcept C185592680 @default.
- W4316649861 hasConcept C192562407 @default.
- W4316649861 hasConcept C23531484 @default.
- W4316649861 hasConcept C2777463227 @default.
- W4316649861 hasConcept C43617362 @default.
- W4316649861 hasConcept C62520636 @default.
- W4316649861 hasConcept C77170095 @default.
- W4316649861 hasConcept C96616956 @default.
- W4316649861 hasConceptScore W4316649861C113196181 @default.
- W4316649861 hasConceptScore W4316649861C119128265 @default.
- W4316649861 hasConceptScore W4316649861C121332964 @default.
- W4316649861 hasConceptScore W4316649861C172120300 @default.
- W4316649861 hasConceptScore W4316649861C179998833 @default.
- W4316649861 hasConceptScore W4316649861C185592680 @default.
- W4316649861 hasConceptScore W4316649861C192562407 @default.
- W4316649861 hasConceptScore W4316649861C23531484 @default.
- W4316649861 hasConceptScore W4316649861C2777463227 @default.
- W4316649861 hasConceptScore W4316649861C43617362 @default.
- W4316649861 hasConceptScore W4316649861C62520636 @default.
- W4316649861 hasConceptScore W4316649861C77170095 @default.
- W4316649861 hasConceptScore W4316649861C96616956 @default.
- W4316649861 hasLocation W43166498611 @default.
- W4316649861 hasOpenAccess W4316649861 @default.
- W4316649861 hasPrimaryLocation W43166498611 @default.
- W4316649861 hasRelatedWork W1964259887 @default.
- W4316649861 hasRelatedWork W1995375582 @default.
- W4316649861 hasRelatedWork W1998279148 @default.
- W4316649861 hasRelatedWork W2013299392 @default.
- W4316649861 hasRelatedWork W2032191029 @default.
- W4316649861 hasRelatedWork W2084062459 @default.
- W4316649861 hasRelatedWork W2134877400 @default.
- W4316649861 hasRelatedWork W2155596957 @default.
- W4316649861 hasRelatedWork W2350318030 @default.
- W4316649861 hasRelatedWork W66516859 @default.
- W4316649861 hasVolume "58" @default.
- W4316649861 isParatext "false" @default.
- W4316649861 isRetracted "false" @default.
- W4316649861 workType "article" @default.